Get full access to one story every week, and to summaries of all other stories. Just create a free account

For about a decade now, the big three medtech companies—Wipro GE Healthcare, Philips Healthcare and Siemens Healthineers—have desperately tried their luck in rural India. And had little success.

They’ve made repeated attempts to sell everything from ECGs to X-rays and infant warmers to the rural population.

So, when S Ganeshprasad, the then-director at GE, spotted Aravamudan Krishna Kumar, the then-managing director at Philips, at a radiology conference in 2015, he was curious about Philips’ latest attempt.

After pleasantries, Kumar told him, “Ganesh, our rural experiment failed. It’s so difficult, you know, to maintain. Business is not very predictable; somewhere it works, somewhere it doesn’t work.”

2010 onwards, all device makers adjusted and readjusted to the market’s needs, building brand-new products from the ground up. Low-cost ultrasounds, ECGs and infant warmers. But the target market didn’t make an easy switch. Philips, it appeared, was the latest casualty. Ganeshprasad’s heart skipped.

You see, GE was to announce its latest experiment that very day. It had a minority 26% stake in GenWorks Health Private Limited, an independent startup that would sell affordable GE devices to rural India, primarily for a commission. This would be the first such investment for the conglomerate. Ganeshprasad would helm GenWorks.

He had been with GE for 18 years, heading sales of ultrasounds, cardiology and other products. Under his tenure, the ultrasound business grew to $100 million in sales, with a 48% marketshare, making it among the most successful portfolios at GE. “Oh my god, I’m getting into it today!” Ganeshprasad recalled thinking last month at his office, which is in an IT park, a 15-minute drive from the GE campus in Bengaluru.

Following GE’s announcement of GenWorks, colleagues had crowded around Ganeshprasad at the conference, he recalled.

All of them had questions. “Why did you do this? You’re so successful!” “Why did you even do this man, c’mon!” “This is stupid, this is a risk you’re taking at this stage of your life. Now GE will just forget this, what will happen to you?”

Selling healthcare to rural Indians is a tough proposition, so medtech companies focus on urban residents. Today, a major portion of the revenue of many companies comes from selling to corporate hospitals and large diagnostic centres in metro cities. That’s unfortunate because most of India’s population—about 833 million people—live in the countryside and go to government or rural hospitals. Many do not have access to MRIs, CT scanners or even low-cost devices (or “boxes”, in industry parlance) such as ECGs. A whole market remains under tapped.

Indian challenge

MNCs realised in the late 90s that equipment sourced from the US does not work well in India. The dimensions, weight and the mobility parameters of these equipment were poor because they had to be fixed and used in one place, said Raghunath Subramanian at IIM Bangalore.

AUTHOR

Gayathri Vaidyanathan

Gayathri writes on health, environment and science. She has reported and produced stories for the Washington Post, Discover, Nature, and the New York Times, amongst other publications. In her last assignment, she was the lead science writer for E&E News in Washington, D.C. E&E News is a news organisation focused on energy and the environment. Over the past decade, Gayathri has travelled across North America, Africa and Asia on long-form reporting projects. She has a master’s in journalism from Columbia University and a bachelor's in biochemistry from McMaster University in Ontario. At The Ken, Gayathri will write on healthcare, the pharmaceutical business and the environment. Based in Bengaluru, you can reach her at gayathri at the rate the-ken.com

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 6 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.